Inecalcitol shows promising preclinical results against hormone-dependent prostate cancer (BioSpace, 8 October 2009)
20 Oct 2009
Inecalcitol (Hybrigenics, Paris) has shown promise in preclinical results in inhibiting the growth of a human hormone-dependent prostate cancer cell line.